Ocrelizumab in a difficult-to-treat rheumatoid arthritis patient

M. Couderc¹, M. Soubrier²

Rheumatology Department, CHU Clermont-Ferrand, France. mcouderc@chu-clermontferrand.fr
Rheumatology Department, CHU Clermont-Ferrand, France.

CER19695
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

Received: 15/01/2026
Accepted : 23/02/2026
In Press: 06/03/2026